Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Marangell

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|May 18, 2000
Augmentation of standard depression therapyL B Marangell
The Journal of Clinical Psychiatry|September 29, 2001
Switching antidepressants for treatment-resistant major depressionL B Marangell
Harvard Review of Psychiatry|September 1, 1996
Evaluating the clinical significance of drug interactions: a systematic approachA M Callahan, L B Marangell, T A Ketter
Acta Psychiatrica Scandinavica|July 28, 2007
Neurostimulation therapies in depression: a review of new modalitiesL B Marangell, M Martinez, R A Jurdi, et al.
The Journal of Dermatological Treatment|October 24, 2017
Epidemiology of mental health comorbidity in psoriasisJ J Wu, S R Feldman, J Koo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 2, 1999
Omega-3 fatty acids and bipolar disorder: a reviewA L Stoll, C A Locke, L B Marangell, et al.
Current Medical Research and Opinion|June 21, 2014
Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*DM Ferguson, E B Dennehy, L B Marangell, et al.
Expert Opinion on Pharmacotherapy|October 5, 2001
Vagus nerve stimulation in depressionP J Goodnick, A J Rush, M S George, et al.
Psychiatry Research|December 1, 1993
Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulationP J Pazzaglia, R M Post, T A Ketter, et al.
Archives of General Psychiatry|August 1, 1994
Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patientsL B Marangell, M S George, G Bissette, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|May 18, 2000
Augmentation of standard depression therapyL B Marangell
The Journal of Clinical Psychiatry|September 29, 2001
Switching antidepressants for treatment-resistant major depressionL B Marangell
Harvard Review of Psychiatry|September 1, 1996
Evaluating the clinical significance of drug interactions: a systematic approachA M Callahan, L B Marangell, T A Ketter
Acta Psychiatrica Scandinavica|July 28, 2007
Neurostimulation therapies in depression: a review of new modalitiesL B Marangell, M Martinez, R A Jurdi, et al.
The Journal of Dermatological Treatment|October 24, 2017
Epidemiology of mental health comorbidity in psoriasisJ J Wu, S R Feldman, J Koo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 2, 1999
Omega-3 fatty acids and bipolar disorder: a reviewA L Stoll, C A Locke, L B Marangell, et al.
Current Medical Research and Opinion|June 21, 2014
Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*DM Ferguson, E B Dennehy, L B Marangell, et al.
Expert Opinion on Pharmacotherapy|October 5, 2001
Vagus nerve stimulation in depressionP J Goodnick, A J Rush, M S George, et al.
Psychiatry Research|December 1, 1993
Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulationP J Pazzaglia, R M Post, T A Ketter, et al.
Archives of General Psychiatry|August 1, 1994
Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patientsL B Marangell, M S George, G Bissette, et al.
Pageof 4